Navigation Links
TriCipher myOneLogin SignatureBook Offers Digital Signatures On-Demand
Date:2/28/2010

LOS GATOS, Calif., Feb. 28 /PRNewswire/ -- TriCipher, a leading provider of Internet identity services, today announced a hosted, on-demand version of its powerful digital signature solution. myOneLogin SignatureBook is an on-demand service that accelerates and streamlines business processes requiring non-repudiable signatures across different groups, organizations or geographic locations. It supports a number of different online credentials, including a clientless credential and the SAFE-BioPharma digital signature widely adopted in healthcare and pharmaceutical industries.

"The SAFE-BioPharma® signature standard provides a high level of trust assurance for digital identities, and is instrumental to speeding processes and reducing costs in the healthcare and pharmaceutical industries," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.  "The TriCipher myOneLogin SignatureBook service offers SAFE-BioPharma members a means of improving business process and simplifying the signing process.  This service will be especially attractive to the growing body of smaller companies which have joined SAFE-BioPharma as a step toward improving their workflows and converting to paperless operations."

myOneLogin SignatureBook collects digital signatures on an electronic document, automatically applying signature policies and streamlining processes of collecting and validating signatures.  It creates an original, signed version of a final document as well as a flattened PDF without active signature blocks, suitable for distribution.  As an on-demand service, myOneLogin SignatureBook is easy to deploy, and is particularly useful for organizations with many business processes requiring signatures by multiple parties.  The service offers several different signature methods, including a TriCipher clientless credential and with credentials compliant with the SAFE-BioPharma digital signature standard. myOneLogin SignatureBook is the in-the-cloud, hosted version of the on-premise TriCipher mySignatureBook digital signing solution.  

"Digital signatures are a natural extension of the Internet identity services that we provide at TriCipher, making it easier and more secure to do business on the web," said John De Santis, chairman and CEO at TriCipher. "The on-premise TriCipher mySignatureBook solution is already adopted in large pharmaceutical organizations. By offering these capabilities as an on-demand service, we deliver on the promise of digital signatures for a wider range of businesses."

For more information, please visit www.myOneLogin.com.

About TriCipher

TriCipher, Inc. provides Internet identity services to protect web and enterprise portals, the people that use them and the business processes that flow through them against fraud and identity theft. TriCipher myOneLogin™ is the first secure, on-demand offering that delivers strong authentication, single sign-on (SSO) and federation capabilities for web applications in a single solution. The TriCipher Armored Credential System™ (TACS) is a unified authentication system that enables companies to deploy and manage multiple types of credentials from a single infrastructure. Through this flexible "Authentication Ladder," TriCipher protects customer investment by adjusting authentication strength to defeat new threats and to meet regulatory changes without the need to implement a new infrastructure. Founded in 2000, TriCipher is headquartered in Los Gatos, Calif. The company is funded by ArrowPath Venture Capital, EPIC Ventures, Intel Capital, RBC Technology Ventures, and Trident Capital.

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

SOURCE TriCipher

Back to top

RELATED LINKS
http://www.tricipher.com
http://www.myOneLogin.com

'/>"/>

SOURCE TriCipher
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Brain study offers insight into causes of autism
2. Synthetic biology offers new opportunities for interdisciplinary collaboration
3. Society of Interventional Radiology hosts oncology therapies Webinar, offers resources
4. Panasonic Offers U.are.U(R) Fingerprint Sensor From DigitalPersona on Stingray JS-950 Point-of-Sale Workstations
5. National new biology initiative offers potential for remarkable and far-reaching benefits
6. New book offers practical advice for unraveling the genetics of complex human diseases
7. New lab test offers better prediction of HIV microbicide safety
8. Biological warfare in bacteria offers hope for new antibiotics
9. MS study offers theory for why repair of brains wiring fails
10. Embryology study offers clues to birth defects
11. Stem cell protein offers a new cancer target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/16/2016)... , Nov. 16, 2016 Sensory ... experience and security for consumer electronics, and ... financial and retail industry, today announced a global ... convenient way to authenticate users of mobile banking ... TrulySecure™ software which requires no specialized ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... 2, 2016 More than $4.3 million was raised ... ( DHMD ). The gala was held at the American ... City and honored Alan Alda and ... health and medicine and the public understanding of science. Since ... the event has raised $40 million for the Laboratory,s research ...
(Date:12/2/2016)... ... 2016 , ... ACEA Biosciences, Inc. announced today that it will be presenting ... the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... trials for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR ...
(Date:12/2/2016)... PRUSSIA, PA (PRWEB) , ... December 01, 2016 , ... ... is through industry-wide collaboration, standardization and a beautiful technology experience. All three tenets were ... more than 100 clinical trial leaders from over 40 sponsor, CRO and site organizations ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
Breaking Biology Technology: